Rigel Pharmaceuticals

Aktienkurs
33.52
Täglich Wechseln
-1.11 -3.19%
Monatlich
-4.11%
Jährlich
51.79%
Q1 Prognose
33.68




Ebit Veränderung Datum
Agenus USD -13.31M 19.08M 2025-03
Amgen USD 3.96B 464M 2025-12
Anika Therapeutics USD -4.28M 3.58M 2025-03
Arrowhead Research USD 40.81M 17.01M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Celldex Therapeutics USD -87.15M 13.54M 2025-12
Daiichi Sankyo JPY 89.54B 42.01B 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
Heron Therapeutics USD -4.46M 5.76M 2024-09
Intrexon USD -26.3M 2.91M 2024-06
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
Karyopharm Therapeutics USD -26.28M 1.84M 2024-09
Ligand Pharmaceuticals USD 158.89M 115.32M 2025-09
MacroGenics USD 20.16M 55.51M 2025-09
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Pfizer USD 4.65B 71M 2025-12
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Rigel Pharmaceuticals USD 447K 1.52M 2024-06
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Veracyte USD 24.63M 1.52M 2025-12


Rigel Pharmaceuticals - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2026.